Accueil
Détail de l'auteur
Auteur H. HAGAN |
Documents disponibles écrits par cet auteur (44)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
H. HAGAN ; D. C. DES JARLAIS ; D. PURCHASE ; S. R. FRIEDMAN ; T. REID ; T. A. BELL |FRANÇAIS : Nous faisons ici le compte rendu de la mise en oeuvre et de l'efficacité potentielle de la plus longue opération d'échange de seringues fonctionnant aux USA, de même que nous comparons nos résultats à ceux d'études portant sur des p[...]Article : Périodique
Objective: There are multiple reasons why females who inject drugs may be more likely to become infected with HIV than males who inject drugs. Where this is the case, special HIV prevention programs for females would be needed. Design: Internat[...]Périodique
D. C. DES JARLAIS ; D. PAONE ; MILLIKEN J. ; C. F. TURNER ; H. MILLER ; GRIBBLE J. ; SHI Q. ; H. HAGAN ; S. R. FRIEDMAN | 1999FRANÇAIS : Une méthode d'entretien (audio-CASI) par ordinateur où les questions sont posées sur l'écran et en même temps à l'aide d'un casque audio et les réponses données par sélection sur le clavier, permet de réduire les sous-déclarations. D[...]Article : Périodique
D. C. DES JARLAIS ; H. HAGAN ; K. ARASTEH ; C. McKNIGHT ; S. SEMAAN ; D. C. PERLMAN |BACKGROUND: Preventing HCV infection among people who inject drugs is a difficult public health challenge. We examined the potential role of intranasal drug use in reducing HCV acquisition. METHODS: Subjects were recruited from IDUs entering t[...]Périodique
S. M. STRAUSS ; J. M. ASTONE ; D. C. DES JARLAIS ; H. HAGAN | 2004ENGLISH : Drug treatment programs are uniquely situated to screen patients for antibodies for hepatitis C virus (HCV), an infectious disease that has reached epidemic proportions among drug users. This paper compares the accessibility and pati[...]Article : Périodique
S. M. JENNESS ; H. HAGAN ; K. L. LIU ; T. WENDEL ; C. S. MURRILL |Sterile syringe access is an important means to reduce HIV risk, but many injection drug users (IDU) who obtain syringes from sterile sources continue to share syringes. We examined the factors associated with continuing syringe sharing in New Y[...]Article : Périodique
S. DEREN ; H. HAGAN ; S. FRIEDMAN ; D. C. DES JARLAIS ; D. PERLMAN ; M. GWADZ ; C. CLELAND ; A. OSBORNE ; J. LUNIEVICZ |As we begin the fourth decade of the epidemic, it is clear that, as demonstrated by the articles in this Special Issue, much has been learned about factors contributing to the decline in HIV prevalence among drug users in New York. However, ther[...]Périodique
T. PERDUE ; H. HAGAN ; H. THIEDE ; VALLEROY L. | 2003ENGLISH : Psychological depression has been identified as a condition that may influence HIV risk behavior among injection drug users (IDUs) and men who have sex with men (MSM). In two Seattle studies,1,228 IDUs and 429 young MSM completed the[...]Périodique
T. PERDUE ; H. HAGAN ; H. THIEDE ; VALLEROY L. | 2003ENGLISH : Psychological depression has been identified as a condition that may influence HIV risk behavior among injection drug users (IDUs) and men who have sex with men (MSM). In two Seattle studies,1,228 IDUs and 429 young MSM completed the[...]Article : Périodique
S. M. STRAUSS ; J. ASTONE-TWERELL ; C. E. MUNOZ-PLAZA ; D. C. DES JARLAIS ; M. GWADZ ; H. HAGAN ; A. OSBORNE ; A. ROSENBLUM |BACKGROUND: In spite of the disproportionate prevalence of hepatitis C virus (HCV) infection among drug users, many remain uninformed or misinformed about the virus. Drug treatment programs are important sites of opportunity for providing HCV ed[...]Périodique
C. E. MUNOZ-PLAZA ; S. M. STRAUSS ; J. M. ASTONE ; D. C. DES JARLAIS ; H. HAGAN | 2004ENGLISH : This paper uses qualitative methods to examine both staff and clients perceptions about the delivery of hepatitis C prevention education services at their respective residential drug treatment programs. Through in-depth discussion wi[...]Périodique
J. M. ASTONE TWERELL ; S. M. STRAUSS ; H. HAGAN ; D. C. DES JARLAIS | 2006ENGLISH : Hepatitis C virus (HCV) infection is the most common blood-borne infectious disease among drug users in the US. Drug treatment programs are ideally situated to assist their clients to obtain HCV medical and support services. Using da[...]Article : Périodique
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN |This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]Périodique
H. HAGAN ; M. H. LATKA ; J. V. CAMPBELL ; E. T. GOLUB ; R. S. GARFEIN ; D. A. THOMAS ; F. KAPADIA ; S. A. STRATHDEE | 2006ENGLISH : Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depres[...]